NASDAQ:NEOG - Nasdaq - US6404911066 - Common Stock - Currency: USD
10.04
-0.25 (-2.43%)
The current stock price of NEOG is 10.04 USD. In the past month the price decreased by -15.98%. In the past year, price decreased by -40.8%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ALC | ALCON INC | 29.66 | 44.76B | ||
COO | COOPER COS INC/THE | 23.97 | 17.70B | ||
ALGN | ALIGN TECHNOLOGY INC | 21.21 | 14.79B | ||
SOLV | SOLVENTUM CORP | 17.91 | 12.87B | ||
MMSI | MERIT MEDICAL SYSTEMS INC | 31.45 | 6.16B | ||
LNTH | LANTHEUS HOLDINGS INC | 11.65 | 5.62B | ||
BLCO | BAUSCH + LOMB CORP | 25.63 | 5.60B | ||
ICUI | ICU MEDICAL INC | 28.72 | 3.99B | ||
XRAY | DENTSPLY SIRONA INC | 10.24 | 3.77B | ||
HAE | HAEMONETICS CORP/MASS | 15 | 3.19B | ||
UFPT | UFP TECHNOLOGIES INC | 38.09 | 2.05B | ||
RXST | RXSIGHT INC | N/A | 1.22B |
Neogen Corp. engages in the development, manufacture, and marketing of food and animal safety products. The company is headquartered in Lansing, Michigan and currently employs 2,917 full-time employees. The firm operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. The Company’s Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.
NEOGEN CORP
620 Lesher Pl
Lansing MICHIGAN 48912 US
CEO: John E. Adent
Employees: 2917
Company Website: https://www.neogen.com/
Investor Relations: https://www.neogen.com/investor-relations
Phone: 15173729200
The current stock price of NEOG is 10.04 USD. The price decreased by -2.43% in the last trading session.
The exchange symbol of NEOGEN CORP is NEOG and it is listed on the Nasdaq exchange.
NEOG stock is listed on the Nasdaq exchange.
10 analysts have analysed NEOG and the average price target is 14.96 USD. This implies a price increase of 49% is expected in the next year compared to the current price of 10.04. Check the NEOGEN CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
NEOGEN CORP (NEOG) has a market capitalization of 2.18B USD. This makes NEOG a Mid Cap stock.
NEOGEN CORP (NEOG) currently has 2917 employees.
NEOGEN CORP (NEOG) has a resistance level at 10.4. Check the full technical report for a detailed analysis of NEOG support and resistance levels.
The Revenue of NEOGEN CORP (NEOG) is expected to decline by -0.33% in the next year. Check the estimates tab for more information on the NEOG EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NEOG does not pay a dividend.
NEOGEN CORP (NEOG) will report earnings on 2025-04-07, after the market close.
The PE ratio for NEOGEN CORP (NEOG) is 25.1. This is based on the reported non-GAAP earnings per share of 0.4 and the current share price of 10.04 USD. Check the full fundamental report for a full analysis of the valuation metrics for NEOG.
The outstanding short interest for NEOGEN CORP (NEOG) is 9.29% of its float. Check the ownership tab for more information on the NEOG short interest.
ChartMill assigns a fundamental rating of 3 / 10 to NEOG. NEOG has only an average score on both its financial health and profitability.
Over the last trailing twelve months NEOG reported a non-GAAP Earnings per Share(EPS) of 0.4. The EPS decreased by -16.67% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -11.75% | ||
ROE | -17.85% | ||
Debt/Equity | 0.33 |
ChartMill assigns a Buy % Consensus number of 82% to NEOG. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of -2.64% and a revenue growth -0.33% for NEOG